Safety Risk with Higher Dose Tofacitnib
U.S. FDA Chief Gottlieb Resigns
FDA Update: Committee Recommends 2 mg Baricitinib Approval; HLH Identified as Serious Adverse Event for Lamotrigine
FDA Teams with Medical Companies in Puerto Rico to Tackle Shortages
Flexion’s Knee Pain Drug Gets FDA Approval
FDA Approves Lesinurad + Allopurinol
FDA Update: Biosiomilar to Adalimumab Receives FDA Approval
FDA Committee Recommends Tofacitinib Approval
Flimsy Evidence Behind Many FDA Approvals
- 1
- 2
- 3
- …
- 11
- Next Page »